Sahajanand Medical Technologies prepares for market debut with Rs 2,000 crore IPO

Mumbai-based stent manufacturer Sahajanand Medical Technologies is planning to raise up to ₹2,000 crore through an IPO, aiming to fuel global growth. Majority stakeholders Morgan Stanley PE Asia and Samara Capital are expected to partially exit their investment, while the company seeks to strengthen its leadership in India's drug-eluting stent market.